These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 2462035)

  • 1. A factor in conditioned medium of rabbit costal chondrocytes inhibits the proliferation of cultured endothelial cells and angiogenesis induced by B16 melanoma: its relation with cartilage-derived anti-tumor factor (CATF).
    Takigawa M; Shirai E; Enomoto M; Pan HO; Suzuki F; Shiio T; Yugari Y
    Biochem Int; 1987 Feb; 14(2):357-63. PubMed ID: 2437926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
    Sheu JR; Fu CC; Tsai ML; Chung WJ
    Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neovascularisation offers a new perspective to glutamine related therapy.
    Maity P; Chakraborty S; Bhattacharya P
    Indian J Exp Biol; 2000 Jan; 38(1):88-90. PubMed ID: 11233093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
    Li L; Wartchow CA; Danthi SN; Shen Z; Dechene N; Pease J; Choi HS; Doede T; Chu P; Ning S; Lee DY; Bednarski MD; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1215-27. PubMed ID: 15001266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cartilage-derived anti-tumor factor (CATF): partial purification and the mechanism of inhibitory action on tumor growth].
    Enomoto M
    Osaka Daigaku Shigaku Zasshi; 1987 Jun; 32(1):91-104. PubMed ID: 2462035
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-tumor factors in cartilage].
    Enomoto M; Takigawa M
    Tanpakushitsu Kakusan Koso; 1987 Jul; 32(8):1060-6. PubMed ID: 3313522
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.
    Olaso E; Vidal-Vanaclocha F
    Methods Mol Med; 2003; 85():79-86. PubMed ID: 12710199
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent progress in the development of anti-tumor metastatic drugs].
    Kumagai H
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):585-91. PubMed ID: 7536403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor angiogenesis in melanoma.
    Marneros AG
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):431-46, vii-viii. PubMed ID: 19464595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro and in-vivo assays for angiogenesis-modulating drug discovery and development.
    Phung MW; Dass CR
    J Pharm Pharmacol; 2006 Feb; 58(2):153-60. PubMed ID: 16451742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling approaches for angiogenesis.
    Taraboletti G; Giavazzi R
    Eur J Cancer; 2004 Apr; 40(6):881-9. PubMed ID: 15120043
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.